Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized TrialMarco Venturini, Paolo Bruzzi, Fulvio Brema et al.|JNCI Journal of the National Cancer Institute|2005Cited by 154
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patientsMarco Venturini, Lucia Del Mastro, Paolo Bruzzi et al.|British Journal of Cancer|2005Cited by 39
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest–Mammella Intergruppo (GONO-MIG) GroupLucia Del Mastro, M. Venturini, Béatrice Dozin et al.|Annals of Oncology|2007Cited by 20
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy (CT) in early breast cancer (BC) patientsLucia Del Mastro, Roberta Rosso, Paolo Bruzzi et al.|Journal of Clinical Oncology|2004Cited by 4